BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Thermo Fisher Scientific and Cellular Biomedicine Group Announce Strategic Partnership to Develop Manufacturing Processes

  The partnership focuses on the research and development of an automated cell therapy manufacturing system.

  November 6, 2017

   · 

  6 min read
• Business

  Myriad Genetics Collaborates With CareFirst BlueCross BlueShield on Coverage with Evidence Development (CED) Study for the Vectra DA Test

  Vectra DA is a pioneering test designed to predict whether patients with RA are at risk for radiographic progression (RP) so that rheumatologists can optimize treatment decisions.

  November 6, 2017

   · 

  8 min read
• Business

  Heron Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2017 and Recent Corporate Progress

  Net product sales of SUSTOL for the three months ended September 30, 2017 were $8.6 million and totaled $20.7 million for the nine months ended September 30, 2017.

  November 6, 2017

   · 

  6 min read
• Business

  Peterson’s Lab Entered Strategic Cooperation With Shanghai Corday Biotech Ltd.

  The five-year agreement includes certain minimum purchases and may be extended through mutual agreement.

  November 6, 2017

   · 

  1 min read
• Business

  Almac Group Enters Strategic Partnership With W5

  The aim is to enhance STEM knowledge and understanding among the next generation of budding scientists through interactive learning.

  November 6, 2017

   · 

  2 min read
• Drug Development

  Omeros’ Extended Improvement in OMS721-Treated Patients With IgA Nephropathy Presented at American Society of Nephrology Annual Meeting

  During the Phase 2 clinical trial, which consisted of 12 weeks of treatment and 6 weeks of follow-up, all patients with IgA nephropathy demonstrated clinically meaningful improvement in proteinuria.

  November 6, 2017

   · 

  8 min read
• Baxter Highlights New Clinical Data Showing HDx Enabled by THERANOVA Removes Mid-Sized Uremic Toxins During Dialysis

  The studies were conducted by clinicians in the United Kingdom and Germany, and were presented at the American Society of Nephrology’s annual Kidney Week Congress, Oct. 31-Nov. 5.

  November 6, 2017

   · 

  6 min read
• Business

  ADMA Biologics Provides Corporate Update and Reports Third Quarter 2017 Financial Results

  The company provided a corporate update, including recent progress with its manufacturing and quality systems, and announced its financial results for the fiscal quarter ended September 30, 2017.

  November 6, 2017

   · 

  15 min read
• Drug Development

  Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa at ASN Kidney Week 2017

  The purpose of this analysis was to demonstrate the effect of treatment with this non-absorbed potassium binder on key markers of mineral metabolism, including calcium and phosphate.

  November 6, 2017

   · 

  7 min read
• Drug Development

  Retrophin Reports Additional Positive Data from Open-Label Extension of Phase II DUET Study of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

  These data were presented today during an oral session at the American Society of Nephrology (ASN) Kidney Week 2017 in New Orleans, LA.

  November 6, 2017

   · 

  8 min read